Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACLASTA for Osteoporosis postmenopausal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 19 adverse event reports in the FDA FAERS database where ACLASTA was used for Osteoporosis postmenopausal.

Most Reported Side Effects for ACLASTA

Side Effect Reports % Deaths Hosp.
Death 233 18.7% 233 17
Fall 138 11.1% 11 56
Pain 82 6.6% 9 29
Pyrexia 70 5.6% 13 39
Malaise 65 5.2% 13 28
Pain in extremity 54 4.3% 7 15
Arthralgia 46 3.7% 4 17
Dyspnoea 46 3.7% 16 22
Vomiting 43 3.5% 4 16
Pneumonia 40 3.2% 21 24
Cerebrovascular accident 39 3.1% 16 23
Hip fracture 38 3.1% 4 14
Back pain 37 3.0% 4 12
Dizziness 36 2.9% 0 11
Headache 36 2.9% 1 9

Other Indications for ACLASTA

Osteoporosis (774) Osteopenia (15) Osteoporotic fracture (11) Osteitis deformans (8) Off label use (7)

Other Drugs Used for Osteoporosis postmenopausal

DENOSUMAB (18,350) ABALOPARATIDE (7,932) PROLIA (1,775) ROMOSOZUMAB-AQQG (1,401) TERIPARATIDE (263) ALENDRONATE (262) ZOLEDRONIC ACID (225) ALENDRONATE\CHOLECALCIFEROL (135) IBANDRONIC ACID (116) ALENDRONIC ACID (105)

Related Pages

ACLASTA Full Profile All Osteoporosis postmenopausal Drugs ACLASTA Demographics ACLASTA Timeline